Expertise in
16
conditions

Dr. Fernando L. Pagan

Neurology
Mgmc LLC
3800 Reservoir Rd Nw, 
Washington, DC 
Offers Telehealth
Expertise in
16
conditions
Mgmc LLC
3800 Reservoir Rd Nw, 
Washington, DC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Fernando Pagan is a Neurologist in Washington, Washington, D.c.. Dr. Pagan is highly rated in 16 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Benign Essential Blepharospasm, Lewy Body Dementia (LBD), and Deep Brain Stimulation.

His clinical research consists of co-authoring 54 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in DC
Hospital Affiliations
Medstar Georgetown University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

MGMC LLC
3800 Reservoir Rd Nw, Washington, DC 20007

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Multicenter, Non-Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered ENT-01 in Improving Constipation and Neurologic Symptoms in Patients With Parkinson's Disease and Constipation Over a 14-week Period
A Multicenter, Non-Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered ENT-01 in Improving Constipation and Neurologic Symptoms in Patients With Parkinson's Disease and Constipation Over a 14-week Period
Enrollment Status: Terminated
Publish Date: March 19, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
Enrollment Status: Withdrawn
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Enrollment Status: Completed
Publish Date: December 27, 2023
Intervention Type: Other, Drug
Study Phase: Phase 1/Phase 2
RESTORE: A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
RESTORE: A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Enrollment Status: Completed
Publish Date: August 23, 2023
Intervention Type: Drug
Study Drug: Droxidopa
Study Phase: Phase 4
Parkinson's Foundation Quality Improvement Initiative
Parkinson's Foundation Quality Improvement Initiative
Enrollment Status: Completed
Publish Date: July 14, 2023
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies (DLB)
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies (DLB)
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Drug
Study Drug: Bosutinib Oral Tablet
Study Phase: Phase 2
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Enrollment Status: Completed
Publish Date: July 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Low Doses of Nilotinib Treatment on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Low Doses of Nilotinib Treatment on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease
Enrollment Status: Unknown
Publish Date: March 14, 2019
Intervention Type: Drug
Study Drug: Nilotinib
Study Phase: Phase 2
View 8 Less Clinical Trials

54 Total Publications

Comparative Safety of Istradefylline Among Parkinson Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies.
Comparative Safety of Istradefylline Among Parkinson Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies.
Journal: Clinical neuropharmacology
Published: January 13, 2025
Similar Doctors
Expertise in
23
conditions
Dr. Mark Hallett
Neurology
Expertise in
23
conditions
Dr. Mark Hallett
Neurology
10 Center Dr Msc 1428, Ninds, Nih, Bldg. 10, Rm 5n226, 
Bethesda, MD 
 (5.0 mi)
301-496-9526
Languages Spoken:
English

Mark Hallett is a Neurologist in Bethesda, Maryland. Dr. Hallett is highly rated in 23 conditions, according to our data. His top areas of expertise are Movement Disorders, Drug Induced Dyskinesia, Focal Dystonia, Essential Tremor, and Deep Brain Stimulation.

Expertise in
21
conditions
Dr. Roger J. Packer
Neurology | Pediatrics
Expertise in
21
conditions
Dr. Roger J. Packer
Neurology | Pediatrics
111 Michigan Ave Nw, 
Washington, DC 
 (3.4 mi)
202-884-2610
Languages Spoken:
English
See accepted insurances

Roger Packer is a Neurologist and a Pediatrics provider in Washington, Washington, D.c.. Dr. Packer is highly rated in 21 conditions, according to our data. His top areas of expertise are Brain Tumor, Neurofibromatosis, Glioma, and Gliomatosis Cerebri.

Expertise in
27
conditions
Dr. Jaishri O. Blakeley
Neurology
Expertise in
27
conditions
Dr. Jaishri O. Blakeley
Neurology

Johns Hopkins University

601 N Caroline St, 
Baltimore, MD 
 (37.0 mi)
410-955-5080
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jaishri Blakeley is a Neurologist in Baltimore, Maryland. Dr. Blakeley is highly rated in 27 conditions, according to our data. Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy. Dr. Blakeley is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pagan's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 37 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile